Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases

Jean E. Lewis, Kerry D. Olsen, Thomas J. Sebo

Research output: Contribution to journalArticle

217 Citations (Scopus)

Abstract

Pathologic factors of predictive value for carcinoma ex pleomorphic adenoma (CXPA), an aggressive salivary gland malignancy, are poorly defined. Because residual mixed tumor may be relatively inconspicuous and various carcinoma subtypes are encountered, misdiagnosis is common. To describe the pathologic features and identify potential prognostic factors, we retrospectively examined 73 cases of CXPA of the major salivary glands treated at Mayo Clinic. Paraffin section immunostaining for keratins (AE1/AE3, CK7, CK20), epithelial membrane antigen, carcinoembryonic antigen, vimentin, actin, S-100 protein, glial fibrillary acidic protein, and p53 and c-erbB-2 oncoproteins was performed in 69 cases. DNA content and proliferation indices were determined by digital image analysis of Feulgen- and MIB-I-stained sections, retrospectively. Survival was calculated by the Kaplan-Meier method, and prognostic variables were analyzed with the log-rank test. The carcinoma component was predominant in 82% of tumors. Adenocarcinoma not otherwise specified (31 cases) and salivary duct carcinoma (24 cases) were the most frequent histologic subtypes. Sixty-two tumors were high grade (Broders 3 or 4). Residual mixed tumor was extensively hyalinized in 54 cases. Pathologic features significantly associated with overall survival included pathologic stage (P = .009), tumor size (P = .012), grade (P = .005), proportion of carcinoma (P = .004), extent of invasion (P = .002), and proliferation index of carcinoma (P = .03). Of 4 patients with intracapsular (noninvasive) carcinoma, none had an adverse outcome. The immunohistochemical profile of CXPA included positive staining reactions in the malignant component for AE1/AE3 in 97% of cases, CK7 in 94%, epithelial membrane antigen in 86%, carcinoembryonic antigen in 75%, vimentin in 52%, and S-100 protein in 29%. Expression of p53 and c-erbB-2 oncoproteins was detected in 41% and 30% of the carcinomas, respectively, but neither was associated with decreased survival. High-grade salivary adenocarcinoma that is difficult to classify should raise the suspicion of possible CXPA. Intracapsular carcinoma has a benign clinical course. Significant prognostic factors in CXPA include tumor stage, grade, proportion of carcinoma, extent of invasion, and proliferation index.

Original languageEnglish (US)
Pages (from-to)596-604
Number of pages9
JournalHuman Pathology
Volume32
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Pleomorphic Adenoma
Carcinoma
Mucin-1
S100 Proteins
Oncogene Proteins
Carcinoembryonic Antigen
Residual Neoplasm
Vimentin
Neoplasms
Survival
Adenocarcinoma
Salivary Ducts
Glial Fibrillary Acidic Protein
Keratins
Diagnostic Errors
Paraffin

Keywords

  • Adenocarcinoma
  • Immunostain
  • Neoplasm
  • Prognostic factors
  • Retrospective study

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Carcinoma ex pleomorphic adenoma : Pathologic analysis of 73 cases. / Lewis, Jean E.; Olsen, Kerry D.; Sebo, Thomas J.

In: Human Pathology, Vol. 32, No. 6, 2001, p. 596-604.

Research output: Contribution to journalArticle

Lewis, Jean E. ; Olsen, Kerry D. ; Sebo, Thomas J. / Carcinoma ex pleomorphic adenoma : Pathologic analysis of 73 cases. In: Human Pathology. 2001 ; Vol. 32, No. 6. pp. 596-604.
@article{e66084815b824f9dbb798a07e0e148e8,
title = "Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases",
abstract = "Pathologic factors of predictive value for carcinoma ex pleomorphic adenoma (CXPA), an aggressive salivary gland malignancy, are poorly defined. Because residual mixed tumor may be relatively inconspicuous and various carcinoma subtypes are encountered, misdiagnosis is common. To describe the pathologic features and identify potential prognostic factors, we retrospectively examined 73 cases of CXPA of the major salivary glands treated at Mayo Clinic. Paraffin section immunostaining for keratins (AE1/AE3, CK7, CK20), epithelial membrane antigen, carcinoembryonic antigen, vimentin, actin, S-100 protein, glial fibrillary acidic protein, and p53 and c-erbB-2 oncoproteins was performed in 69 cases. DNA content and proliferation indices were determined by digital image analysis of Feulgen- and MIB-I-stained sections, retrospectively. Survival was calculated by the Kaplan-Meier method, and prognostic variables were analyzed with the log-rank test. The carcinoma component was predominant in 82{\%} of tumors. Adenocarcinoma not otherwise specified (31 cases) and salivary duct carcinoma (24 cases) were the most frequent histologic subtypes. Sixty-two tumors were high grade (Broders 3 or 4). Residual mixed tumor was extensively hyalinized in 54 cases. Pathologic features significantly associated with overall survival included pathologic stage (P = .009), tumor size (P = .012), grade (P = .005), proportion of carcinoma (P = .004), extent of invasion (P = .002), and proliferation index of carcinoma (P = .03). Of 4 patients with intracapsular (noninvasive) carcinoma, none had an adverse outcome. The immunohistochemical profile of CXPA included positive staining reactions in the malignant component for AE1/AE3 in 97{\%} of cases, CK7 in 94{\%}, epithelial membrane antigen in 86{\%}, carcinoembryonic antigen in 75{\%}, vimentin in 52{\%}, and S-100 protein in 29{\%}. Expression of p53 and c-erbB-2 oncoproteins was detected in 41{\%} and 30{\%} of the carcinomas, respectively, but neither was associated with decreased survival. High-grade salivary adenocarcinoma that is difficult to classify should raise the suspicion of possible CXPA. Intracapsular carcinoma has a benign clinical course. Significant prognostic factors in CXPA include tumor stage, grade, proportion of carcinoma, extent of invasion, and proliferation index.",
keywords = "Adenocarcinoma, Immunostain, Neoplasm, Prognostic factors, Retrospective study",
author = "Lewis, {Jean E.} and Olsen, {Kerry D.} and Sebo, {Thomas J.}",
year = "2001",
doi = "10.1053/hupa.2001.25000",
language = "English (US)",
volume = "32",
pages = "596--604",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Carcinoma ex pleomorphic adenoma

T2 - Pathologic analysis of 73 cases

AU - Lewis, Jean E.

AU - Olsen, Kerry D.

AU - Sebo, Thomas J.

PY - 2001

Y1 - 2001

N2 - Pathologic factors of predictive value for carcinoma ex pleomorphic adenoma (CXPA), an aggressive salivary gland malignancy, are poorly defined. Because residual mixed tumor may be relatively inconspicuous and various carcinoma subtypes are encountered, misdiagnosis is common. To describe the pathologic features and identify potential prognostic factors, we retrospectively examined 73 cases of CXPA of the major salivary glands treated at Mayo Clinic. Paraffin section immunostaining for keratins (AE1/AE3, CK7, CK20), epithelial membrane antigen, carcinoembryonic antigen, vimentin, actin, S-100 protein, glial fibrillary acidic protein, and p53 and c-erbB-2 oncoproteins was performed in 69 cases. DNA content and proliferation indices were determined by digital image analysis of Feulgen- and MIB-I-stained sections, retrospectively. Survival was calculated by the Kaplan-Meier method, and prognostic variables were analyzed with the log-rank test. The carcinoma component was predominant in 82% of tumors. Adenocarcinoma not otherwise specified (31 cases) and salivary duct carcinoma (24 cases) were the most frequent histologic subtypes. Sixty-two tumors were high grade (Broders 3 or 4). Residual mixed tumor was extensively hyalinized in 54 cases. Pathologic features significantly associated with overall survival included pathologic stage (P = .009), tumor size (P = .012), grade (P = .005), proportion of carcinoma (P = .004), extent of invasion (P = .002), and proliferation index of carcinoma (P = .03). Of 4 patients with intracapsular (noninvasive) carcinoma, none had an adverse outcome. The immunohistochemical profile of CXPA included positive staining reactions in the malignant component for AE1/AE3 in 97% of cases, CK7 in 94%, epithelial membrane antigen in 86%, carcinoembryonic antigen in 75%, vimentin in 52%, and S-100 protein in 29%. Expression of p53 and c-erbB-2 oncoproteins was detected in 41% and 30% of the carcinomas, respectively, but neither was associated with decreased survival. High-grade salivary adenocarcinoma that is difficult to classify should raise the suspicion of possible CXPA. Intracapsular carcinoma has a benign clinical course. Significant prognostic factors in CXPA include tumor stage, grade, proportion of carcinoma, extent of invasion, and proliferation index.

AB - Pathologic factors of predictive value for carcinoma ex pleomorphic adenoma (CXPA), an aggressive salivary gland malignancy, are poorly defined. Because residual mixed tumor may be relatively inconspicuous and various carcinoma subtypes are encountered, misdiagnosis is common. To describe the pathologic features and identify potential prognostic factors, we retrospectively examined 73 cases of CXPA of the major salivary glands treated at Mayo Clinic. Paraffin section immunostaining for keratins (AE1/AE3, CK7, CK20), epithelial membrane antigen, carcinoembryonic antigen, vimentin, actin, S-100 protein, glial fibrillary acidic protein, and p53 and c-erbB-2 oncoproteins was performed in 69 cases. DNA content and proliferation indices were determined by digital image analysis of Feulgen- and MIB-I-stained sections, retrospectively. Survival was calculated by the Kaplan-Meier method, and prognostic variables were analyzed with the log-rank test. The carcinoma component was predominant in 82% of tumors. Adenocarcinoma not otherwise specified (31 cases) and salivary duct carcinoma (24 cases) were the most frequent histologic subtypes. Sixty-two tumors were high grade (Broders 3 or 4). Residual mixed tumor was extensively hyalinized in 54 cases. Pathologic features significantly associated with overall survival included pathologic stage (P = .009), tumor size (P = .012), grade (P = .005), proportion of carcinoma (P = .004), extent of invasion (P = .002), and proliferation index of carcinoma (P = .03). Of 4 patients with intracapsular (noninvasive) carcinoma, none had an adverse outcome. The immunohistochemical profile of CXPA included positive staining reactions in the malignant component for AE1/AE3 in 97% of cases, CK7 in 94%, epithelial membrane antigen in 86%, carcinoembryonic antigen in 75%, vimentin in 52%, and S-100 protein in 29%. Expression of p53 and c-erbB-2 oncoproteins was detected in 41% and 30% of the carcinomas, respectively, but neither was associated with decreased survival. High-grade salivary adenocarcinoma that is difficult to classify should raise the suspicion of possible CXPA. Intracapsular carcinoma has a benign clinical course. Significant prognostic factors in CXPA include tumor stage, grade, proportion of carcinoma, extent of invasion, and proliferation index.

KW - Adenocarcinoma

KW - Immunostain

KW - Neoplasm

KW - Prognostic factors

KW - Retrospective study

UR - http://www.scopus.com/inward/record.url?scp=0034950591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034950591&partnerID=8YFLogxK

U2 - 10.1053/hupa.2001.25000

DO - 10.1053/hupa.2001.25000

M3 - Article

C2 - 11431714

AN - SCOPUS:0034950591

VL - 32

SP - 596

EP - 604

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 6

ER -